null

Sirexatamab (Anti-DKK1) Biosimilar Antibody

SKU:
HDBS0110
Product Type:
Biosimilar Antibody
Antibody Type:
Monoclonal Antibody
Protein:
DKK1
Reactivity:
Human
Host Species:
Chimeric Humanized
Isotype:
IgG4
€373
Frequently bought together:

Description

system_update_altDatasheet

Sirexatamab (Anti-DKK1) Biosimilar Antibody (HDBS0110)

The Sirexatamab Biosimilar Anti-DKK1 Antibody is a cutting-edge biopharmaceutical product developed by Assay Genie for research purposes. This monoclonal antibody specifically targets DKK1, a protein known for its role in regulating the Wnt signaling pathway, which is crucial for cell proliferation and differentiation.Through its high specificity and affinity for DKK1, this antibody enables researchers to investigate the biological functions of DKK1 in various cellular processes, particularly in the context of cancer biology and developmental biology. Its application in techniques such as ELISA, immunofluorescence, and flow cytometry allows for precise and accurate detection of DKK1 in cell samples.

The Sirexatamab Biosimilar Anti-DKK1 Antibody holds great potential for advancing the understanding of DKK1-mediated signaling pathways and their implications in disease development. By studying the interactions of DKK1 with its binding partners and downstream effectors, researchers can uncover new therapeutic targets for cancer and other Wnt signaling-related disorders.Overall, this antibody serves as a valuable tool for researchers in the fields of oncology, immunology, and molecular biology, offering insights that may lead to the development of novel treatment strategies for DKK1-associated diseases.